Pristanic acid-d6 (>90%)

Pristanic acid-d6 (>90%) is the deuterium labeled Pristanic acid (HY-113024) . Pristanic acid is an endogenous metabolite present in Blood that can be used for the research of Alpha Methylacyl CoA Racemase Deficiency and Zellweger Syndrome[1][2][3].

Product Specifications

UNSPSC

12352211

Target

Endogenous Metabolite; Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Metabolic Disease

Smiles

OC(C([2H])(C([2H])([2H])[2H])C(CCC(C)CCCC(C)CCCC(C)C)([2H])[2H])=O

Molecular Formula

C19H32D6O2

Molecular Weight

304.54

References & Citations

[1]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720. |[2]McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72 (3) :396-9.|[3]Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44 (5) :720-30.